In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.

The in vitro and in vivo activities of a new benzoxazinorifamycin, KRM-1648 (KRM), against Mycobacterium tuberculosis were studied. The MIC at which 50% of the isolates are inhibited (MIC50) and the MIC90 of KRM for 30 fresh isolates of M. tuberculosis measured by the BACTEC 460 TB System were 0.016...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hirata, T, Saito, H, Tomioka, H, Sato, K, Jidoi, J, Hosoe, K, Hidaka, T
Формат: Artigo
Язык:Inglês
Опубликовано: 1995
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC162932/
https://ncbi.nlm.nih.gov/pubmed/8619585
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы